Article | May 24, 2023

EMA's Updated Guidelines: Key Changes For Computerized Systems & Electronic Data In Clinical Trials

GettyImages-1182541081 data guidelines

To stay aligned with technological advancements and industry best practices, the European Medicines Agency (EMA) regularly updates its guidelines, ensuring their relevance and currency. In a recent regulation modification, the EMA released new guidance regarding computerized systems and electronic data in clinical trials as compared to the reflection paper on electronic data collection tools in clinical trials this guideline replaces.

The new guideline sheds light on the evolving landscape of electronic data management in clinical trials, aligning with themes seen in other regulations put forth by the EMA, such as EudraLex Annex 11. Stay up-to-date with these latest developments by accessing the full article below.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader